Webinar: Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Children - European Medical Journal

Webinar: Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Children


In this webinar focusing on Autosomal Dominant Polycystic Kidney Disease (ADPKD) in Children, Djalila Mekhali, University Hospital of Leuven, Belgium, presents a comprehensive account of the disease and its progression.

During this webinar Prof Mekhali provides:

  • an overview of disease manifestations, progression, and pharmacological management in adults;
  • a discussion of the paediatric spectrum, clinical manifestations, and pharmacological management of ADPKD in children; and
  • an introduction to the global paediatric initiative of ADPKD registry.

This is a webinar for nephrologists, paediatricians and general practitioners wishing to expand their knowledge on ADPKD.

Prof. Dr. Djalila Mekahli is a staff member of the Department of Paediatric Nephrology and Organ Transplantation of the University Hospitals Leuven, Belgium. She trained in pediatric nephrology and transplantation in the University Hospital of Lyon (France) and in Great Ormond Street Hospital in London (UK). She is leading the pediatric ADPKD clinic including a large cohort of almost 100 children. She initiated a longitudinal biobank of this cohort and is very active in clinical and biological research aiming at identifying and validating early biomarkers for ADPKD. She is a Professor at the university KU Leuven, Belgium and leader of the PKD research group with extensive experience in human cell models from ADPKD patients from early (urine) to late (nephrectomies) disease stages. She has recently initiated the unique international ADPKD children registry including already ADPKD children (https://www.adpedkd.org).  She is the co-chair of the workgroup for autosomal dominant structural kidney disorders (including ADPKD and TSC) from the European Reference Network for Rare Kidney Diseases (ERKNet) (https://erknet.org/index.php?id=39).

Join our mailing list

To receive the EMJ updates straight to your inbox free of charge, please click the button below.
Join Now